Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617001046392Phase 3Completed
Phase 3, open-label, single-arm trial of flucloxacillin in Not applicable, sponsored by Canterbury District Health Board. Primary endpoints: Total flucloxacillin plasma concentrations and Free flucloxacillin plasma concentrations. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617001046392.